Home > Category > Inhibitory Antibodies > Anti-CD138 (indatuximab ravtansine biosimilar) mAb

Anti-CD138 (indatuximab ravtansine biosimilar) mAb

ChemLeader 98+%

Catalog No：CLA1045 CAS No.：1238517-16-2 MDLNo： Formula： MW：

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
1 mg	3-5days	$1500.00	Visible after login	- +
5 mg	3-5days	$3800.00	Visible after login	- +
10 mg	3-5days	$6200.00	Visible after login	- +

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Anti-CD138 (indatuximab ravtansine biosimilar) mAb
CAS	1238517-16-2
Storage condition	2 weeks, 2-8℃ under sterile conditions after reconstitution. Avoid repeated freeze-thaw. -80°C for a long-term storage.

Product details

Indatuximab ravtansine (BT062) is an antibody-drug conjugate (ADC) based on a murine/human chimeric form of B-B4 (CD138-specific antibody), which is covalently conjugated to the maytansinoid drug DM4 via a disulfide bond-based linker. Maytansinoids are structural analogs of the cytotoxic agent maytansine, which has been evaluated in phase I and phase II clinical trials.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CLA1045

Anti-CD138 (indatuximab ravtansine biosimilar) mAb

1238517-16-2 98+%